Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

标题
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 104, Issue 1, Pages 68-74
出版商
Springer Nature
发表日期
2010-11-24
DOI
10.1038/sj.bjc.6605972

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search